pubmed.ncbi.nlm.nih.gov

In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR - PubMed

  • ️Tue Jan 01 2019

Review

In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR

Gopal Pawar et al. Front Pharmacol. 2019.

Abstract

A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.

Keywords: chemicals; databases; drugs; in silico; safety assessment.

PubMed Disclaimer

Figures

GRAPHICAL ABSTRACT
GRAPHICAL ABSTRACT

Word cloud of key words in the databases reviewed.

Figure 1
Figure 1

Chart showing the number of databases within each group. DI, Drug Information; CT, Clinical trials; PV, Pharmacovigilance; PPI, Protein-protein interactions; Animal Alt, Animal alternatives.

Similar articles

Cited by

References

    1. Aksoy B. A., Dancik V., Smith K., Mazerik J. N., Ji Z., Gross B., et al. . (2017). CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network. Database 2017. bax054. 10.1093/database/bax054 - DOI - PMC - PubMed
    1. Alcántara R., Onwubiko J., Cao H., Matos P. D., Cham J. A., Jacobsen J., et al. . (2013). The EBI enzyme portal. Nucleic Acids Res. 41, D773–D780. 10.1093/nar/gks1112 - DOI - PMC - PubMed
    1. Alexander-Dann B., Pruteanu L. L., Oerton E., Sharma N., Berindan-Neagoe I., Módos D., et al. . (2018). Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data. Mol. Omics 14, 218–236. 10.1039/C8MO00042E - DOI - PMC - PubMed
    1. Alonso-Lopez D., Gutierrez M. A., Lopes K. P., Prieto C., Santamaria R., De Las Rivas J. (2016). APID interactomes: providing proteome-based interactomes with controlled quality for multiple species and derived networks. Nucleic Acids Res. 44, W529–W535. 10.1093/nar/gkw363 - DOI - PMC - PubMed
    1. Anderle P., Duval M., Draghici S., Kuklin A., Littlejohn T. G., Medrano J. F., et al. . (2003). Gene expression databases and data mining. Biotechniques (Suppl.), 36–44. 10.2144/mar03anderle - DOI - PubMed

Publication types